Shiti, Assad
Goldfracht, Idit http://orcid.org/0000-0002-2575-2159
Shaheen, Naim
Protze, Stephanie
Gepstein, Lior http://orcid.org/0000-0002-5351-7391
Article History
Received: 15 June 2020
Accepted: 4 February 2021
First Online: 19 March 2021
Competing interests
: S.P. has an active consulting agreement with BlueRock Therapeutics LP and received funding from sponsored research agreements with BlueRock Therapeutics LP. The remaining authors declare no competing interests.